Randomized, Double Blind, Placebo-Controlled, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary Angioedema
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006841/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the efficacy and safety of Icatibant, a bradykinin
antagonist in the treatment of acute cutaneous and/or abdominal attacks in patients with
hereditary angioedema (HAE).
提供机构：
Vivli
创建时间：
2021-04-07
